>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
反义寡核苷酸抑制survivin表达来增强乳腺癌细胞株MCF-7和MDA-MB-231对多西他赛敏感性的研究
作者:张静1  姜藻2 
单位:1. 蚌埠市中心医院 肿瘤内科, 安徽 蚌埠 233000;
2. 东南大学附属中大医院 肿瘤科, 江苏 南京 210009
关键词:生存素 反义寡核苷酸 多西他赛 乳腺癌细胞株 
分类号:R737.9
出版年·卷·期(页码):2009·28·第一期(6-10)
摘要:

目的: 探讨利用反义寡核甘酸(ASODN)技术封闭乳腺癌细胞株survivin基因,观察survivin基因表达下调能否诱导细胞凋亡及增强对多西他赛(docetaxel)药物敏感性。方法: Survivin ASODN单独及联合多西他赛处理乳腺癌细胞株MCF-7和MDA-MB-231,RT-PCR检测survivin mRNA的表达,免疫细胞化学方法和Western blotting检测survivin蛋白表达,倒置显微镜观察细胞形态变化,MTT法检测细胞的生长抑制率。结果: Survivin ASODN可下调人乳腺癌细胞株中survivin mRNA 和蛋白质的表达;survivin ASODN 与多西他赛联合用药组相比对照组和多西他赛组可明显抑制细胞株的生长(P<0.01)。结论: Survivin ASODN明显抑制survivin基因在乳腺癌细胞株MCF-7和MDA-MB-231中的转录及翻译,明显提高乳腺癌对多西他赛的敏感性。

Objective Through interfering the expression of survivin with survivin ASODN,to investigate the effect of downregulation of survivin on cell apoptosis and chemosensitivity to docetaxel in breast cancer cells.Methods The breast cancer cells MCF-7 and MDA-MB-231 were treated with survivin ASODN and docetaxel alone or together.The expression of survivin mRNA was assessed by RT-PCR.The expression of survivin protein was tested with immunocytochemistry and Western blotting analysis.Cell morphological transformation was observed with invertedmicroscope.The inhibitive rates of the cells was determined by MTT.Results Survivin ASODN could down-regulate the expression of survivin.The growth of breast cancer cells can be significantly inhibited by combined survivin ASODN and docetaxel group.The effect was higher than that of control and docetaxel group(P<0.01).Conclusion These results show that by survivin ASODN,survivin expression can be effectively decreased at both transcriptional and translational level.The reduction of survivin expression exerts significant effects on chemosensitivity of breast cancer cells MCF-7 and MDA-MB-231 to docetaxel.

参考文献:

[1] ALTIERI D C.Validating survivin as a cancer therapeutic target[J].Nat Rev Cancer,2003,3(1):46-54.
[2] YAMASHITA S,MASUDA Y,KURIZAKI T,et al.Survivin expression predicts early recurrence in early-stage breast cancer[J].Anticancer Res,2007,27(4C):2803-2808.
[3] 张保宁.乳腺癌临床研究的回顾与展望[J].中华医学杂志,2005,81(1):1-5.
[4] 何声秀,吕丽荣.转移性乳腺癌化疗进展[J].现代诊断与治疗,2002,13(3):155-158.
[5] OLIE R A,SIMOES-WUST A P,BAUMAN B,et al.A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy[J].Cancer Res,2000,60(11):2805-2809.
[6] HOU J Q,HE J,WEN D G,et al.Survivin mRNA expression in urine as a biomarker for patients with transitional cell carcinoma of bladder[J].CMJ,2006,119(13):1118-1120.
[7] CALADS H,JIANG Y,HOLLOWAY M P,et al.Survivin splice variants regulate the balance between proliferation and cell death[J].Oncogene,2005,24(12):1994-2007.
[8] ANGELL H.A study into the potential role of survivin localization in resistance to drug-induced apoptosis[J].Bioscience Horizons,2008,1(2):85-91.
[9] NABHOLTZ J M,RESSE D M,LINDSAY M A,et al.Evidence for the use of chemotherapy in breast cancer[J].Int J Clin Oncol,2002,7( 4):254-264.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 414556 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364